You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

t1/2λz

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer Trial

Completed
  • Colorectal Cancer
    • (no location specified)
    Nov 8, 2023

    Localized T1-T2 Prostate Cancer Trial in Qionghai (SpaceOAR Treatment)

    Recruiting
    • Localized T1-T2 Prostate Cancer
    • SpaceOAR Treatment
    • Qionghai, Hainan, China
      Boao First Life Care Center-Hospital
    Jan 17, 2023

    Stereotactic Margins in Localized Bronchial Cancer (T1/T2a, N0)

    Recruiting
    • Bronchial Cancer
      • Strasbourg, France
        Service de chirurgie thoracique - CHU de Strasbourg - France
      Oct 28, 2022

      Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)

      Not yet recruiting
      • Oral Squamous Cell Carcinoma
      • Neck Dissection
      • Elective neck dissection
      • Therapeutic neck dissection
      • (no location specified)
      Apr 10, 2023

      Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)

      Recruiting
      • Locally Advanced Nasopharyngeal Carcinoma
      • 2 cycles induction chemotherapy
      • 3 cycles induction chemotherapy
      • Guangzhou, Other (Non U.s.), China
        First Affiliated Hospital, Sun Yat-Sen University
      May 6, 2023

      Prostate Cancer Trial in Taiyuan (SpaceOAR Hydrogel)

      Recruiting
      • Prostate Cancer
      • SpaceOAR Hydrogel
      • Taiyuan, Shanxi, China
        Shanxi Cancer Hospital
      Feb 9, 2023

      NK-T-Cell Lymphoma, Extranodal Trial in Shanghai (4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen

      Not yet recruiting
      • NK-T-Cell Lymphoma, Extranodal
      • 4 cycles of ESA regimen with sandwiched radiotherapy
      • +2 more
      • Shanghai, Shanghai, China
        Ruijin Hospital
      Sep 29, 2023

      Type 2 Diabetes, Myocardial Fibrosis, Myocardial Inflammation Trial in Seattle (dapagliflozin, Placebo)

      Completed
      • Type 2 Diabetes Mellitus
      • +2 more
      • Seattle, Washington
        University of Washington
      Jan 9, 2023

      Type 1 Diabetes, Type 2 Diabetes Trial in Tunbridge Wells (Four Week Self-Compassion Course)

      Not yet recruiting
      • Type 1 Diabetes
      • Type 2 Diabetes
      • Four Week Self-Compassion Course
      • Tunbridge Wells, United Kingdom
        Salomons Institute for Applied Psychology, Canterbury Christ Chu
      Mar 1, 2023

      Advanced Solid Tumor Trial in Chengdu (Dual-targeting CLDN18.2 and PD-L1 CAR-T cells)

      Not yet recruiting
      • Advanced Solid Tumor
      • Dual-targeting CLDN18.2 and PD-L1 CAR-T cells
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      Oct 9, 2023

      Stomach Tumor Trial (Trastuzumab deruxtecan, Afatinib)

      Not yet recruiting
      • Stomach Neoplasm
      • (no location specified)
      Oct 16, 2023

      Cancer T1-N0 or T2-N0 of the Oral Cavity Trial in Montpellier (outpatient surgery for T1-N0 or T2-N0 cancers of the oral cavity

      Recruiting
      • Cancer T1-N0 or T2-N0 of the Oral Cavity
      • outpatient surgery for T1-N0 or T2-N0 cancers of the oral cavity or oropharynx with lymph node search
      • Montpellier, Hérault, France
        Gui de Chauliac Hospital, ENT Department 80 rue Augustin Fliche
      Mar 30, 2022

      Breast Cancer, Axillary Nodal Disease, Female Breast Cancer Trial (Breast Surgery (BCS or mastectomy) with TAD/SNB, Adjuvant

      Not yet recruiting
      • Breast Cancer
      • +5 more
      • Breast Surgery (BCS or mastectomy) with TAD/SNB
      • Adjuvant Radiation Therapy
      • (no location specified)
      Oct 24, 2023

      Trastuzumab Emtansine as Therapy in Chinese HER2 Positive

      Not yet recruiting
      • Breast Cancer
      • Trastuzumab emtansine
      • (no location specified)
      Jul 13, 2023

      Nasopharyngeal Carcinoma, T2-3N0 or T1-2N1, EBV-DNA=4000 Copy/ml Trial in Guangzhou (Toripalimab, IMRT)

      Recruiting
      • Nasopharyngeal Carcinoma
      • +2 more
      • Guangzhou, Guangdong, China
        Yanqun Xiang
      Feb 7, 2022

      Healthy Subjects, Obesity, T2DM (Type 2 Diabetes) Trial in Changchun (HEC88473 injection, Placebo)

      Completed
      • Healthy Subjects
      • +2 more
      • HEC88473 injection
      • Placebo
      • Changchun, Jilin, China
        The First Hospital of Jilin University
      Jul 14, 2023

      Renal Cell Carcinoma Trial in Sohag (laparoscopic partial nephrectomy)

      Not yet recruiting
      • Renal Cell Carcinoma
      • laparoscopic partial nephrectomy
      • Sohag, Egypt
        Sohag University Hospital
      Aug 3, 2022

      Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

      Not yet recruiting
      • Glioblastoma
      • (no location specified)
      Sep 25, 2023

      Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

      Not yet recruiting
      • Neuroendocrine Tumor (NET)
      • Colorectal Cancer (CRC)
      • CHM-2101 CAR-T cells
      • (no location specified)
      Sep 20, 2023

      Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • Aldesleukin
      • +12 more
      • Los Angeles, California
        USC / Norris Comprehensive Cancer Center
      Aug 9, 2023

      Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

      Not yet recruiting
      • Cancer
      • +3 more
      • 177Lu-PSMA-I&T - escalating renal absorbed dose
      • 177Lu-PSMA-I&T - recommended phase 2 regime
      • (no location specified)
      Jun 14, 2023

      Healthy Adult Subjects Trial in Hefei (Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL), Test drug (T2):

      Not yet recruiting
      • Healthy Adult Subjects
      • Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL)
      • +2 more
      • Hefei, Anhui, China
        The Second Hospital of Anhui Medical University
      Jun 14, 2023

      Gastric Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting Claudin18.2)

      Recruiting
      • Gastric Cancer
      • Chimeric antigen receptor T cell preparation targeting Claudin18.2
      • Qingdao, Shandong, China
        The Affiliated Hospital of Qingdao University
      Jul 11, 2023

      B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)

      Recruiting
      • B-Cell Lymphoma
      • +4 more
      • 19(T2)28z1xx TRAC T cell
      • New York, New York
        Memorial Sloan Kettering Cancer Center (All Protocol Activities)
      Feb 24, 2023

      Advanced Breast Cancer, Objective Response Rate, Trastuzumab Emtansine Trial in Nanjing (Trastuzumab Emtansine (T-DM1))

      Recruiting
      • Advanced Breast Cancer
      • +2 more
      • Trastuzumab Emtansine (T-DM1)
      • Nanjing, Jiangsu, China
        JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
      Nov 5, 2023